Cargando…

Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients

Detalles Bibliográficos
Autores principales:	Witte, Hanno M., Hertel, Nadine, Merz, Hartmut, Bernd, Heinz-Wolfram, Bernard, Veronica, Stölting, Stephanie, von Bubnoff, Nikolas, Feller, Alfred C., Gebauer, Niklas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260224/ https://www.ncbi.nlm.nih.gov/pubmed/32471974 http://dx.doi.org/10.1038/s41408-020-0327-0

Ejemplares similares

Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
por: Witte, Hanno M., et al.
Publicado: (2022)

Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
por: Hertel, Nadine, et al.
Publicado: (2021)

Primary refractory plasmablastic lymphoma: A precision oncology approach
por: Witte, Hanno M., et al.
Publicado: (2023)

Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
por: Künstner, Axel, et al.
Publicado: (2021)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

P1233: PRIMARY REFRACTORY PLASMABLASTIC LYMPHOMA: A PRECISION ONCOLOGY APPROACH
por: Witte, H., et al.
Publicado: (2022)

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
por: Olschewski, Vito, et al.
Publicado: (2021)

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
por: Künstner, Axel, et al.
Publicado: (2022)

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
por: Gebauer, Niklas, et al.
Publicado: (2021)

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation
por: Witte, Hanno M., et al.
Publicado: (2020)

P1232: PRINCIPLES OF PRECISION ONCOLOGY IN PRIMARY REFRACTORY HIGH-GRADE B-CELL LYMPHOMA WITH MYC-, BCL2 AND/OR BCL6 REARRANGEMENTS (HGBL-DH/TH)
por: Witte, H., et al.
Publicado: (2022)

Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing
por: Gebauer, Niklas, et al.
Publicado: (2021)

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System
por: Gebauer, Niklas, et al.
Publicado: (2022)

Pyrosequencing as a Fast and Reliable Method in Detecting the MYD88 p.L265P Mutation in Decalcified Formalin-Fixed and Paraffin-Embedded Tissues
por: Gebauer, Niklas, et al.
Publicado: (2014)

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma
por: Witte, Hanno, et al.
Publicado: (2018)

Plasmablastic Lymphoma of the Stomach With C-MYC Rearrangement in an Immunocompetent Young Adult: A Case Report
por: Huang, Xin, et al.
Publicado: (2015)

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma
por: Garcia-Reyero, Julia, et al.
Publicado: (2020)

Elastofibroma Dorsi: Clinicopathological Analysis of 76 Cases
por: El Hammoumi, Massine, et al.
Publicado: (2014)

Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China
por: Shi, Di, et al.
Publicado: (2022)

Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma
por: Choi, Qute, et al.
Publicado: (2010)

KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice
por: Rosean, T R, et al.
Publicado: (2016)

Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement
por: Ise, Mikiko, et al.
Publicado: (2018)

Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
por: Gebauer, Niklas, et al.
Publicado: (2021)

Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia
por: Elyamany, Ghaleb, et al.
Publicado: (2015)

Plasmablastic Lymphoma: A Clinicopathological Study from a Tertiary Care Cancer Center in South India
por: Mundada, Manasi C., et al.
Publicado: (2020)

Plasmablastic lymphoma in Malawi
por: Zuze, Takondwa, et al.
Publicado: (2018)

Orbital plasmablastic lymphoma
por: Bloch, Edward, et al.
Publicado: (2017)

Plasmablastic lymphoma: An update
por: Bailly, Jenique, et al.
Publicado: (2022)

Plasmablastic Lymphoma or Plasmablastic Myeloma: A Case of Post-Transplant Lymphoproliferative Disorder
por: Ramadas, Poornima, et al.
Publicado: (2021)

Sensitive and reliable detection of Kit point mutation Asp 816 to Val in pathological material
por: Kähler, Christian, et al.
Publicado: (2007)

Gastrointestinal stromal tumors with pseudocystic change mimicking a pancreatic tumor: two case reports
por: Pauser, Ursula, et al.
Publicado: (2009)

Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients
por: Loghavi, Sanam, et al.
Publicado: (2015)

Primary leptomeningeal plasmablastic lymphoma
por: Mathews, Marlon S., et al.
Publicado: (2011)

Plasmablastic lymphoma: current perspectives
por: Lopez, Andres, et al.
Publicado: (2018)

Duodenal localization of plasmablastic myeloma
por: Licci, Stefano
Publicado: (2017)

MYC Deregulation in Gastric Cancer and Its Clinicopathological Implications
por: de Souza, Carolina Rosal Teixeira, et al.
Publicado: (2013)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
por: von Bubnoff, Nikolas, et al.
Publicado: (2018)

Plasmablastic lymphoma mimicking orbital cellulitis
por: Barkhuysen, Richard, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_skmduc3e14f0eapa72meavfh02